BackCidara Therapeutics Overview

Cidara Therapeutics Long Term Debt

Latest long-term debt for CDTX: $420K.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$424000.00
82.05% YoYΔ $-1.94M vs prior year quarter

Peer average

Loading

Cidara Therapeutics Long Term Debt History

Loading

Cidara Therapeutics vs. peers: Long Term Debt Comparison

Loading

Cidara Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cidara Therapeutics (CDTX) FAQ

As of the most recent data (September 2025), CDTX shows a long-term debt of $420K. That compares with $2.4M in the prior-year period — down 82.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDTX's long-term debt is now $420K (was $2.4M) — a 82.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cidara Therapeutics is outperforming or lagging.

Tracking CDTX's long-term debt over time shows whether Cidara Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $420K That compares with $2.4M in the prior-year period — down 82.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Cidara Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $420K) with ownership activity and broader fundamentals.

Cidara Therapeutics's long-term debt is $420K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.